St. Thomas' Hospital, London
“Downton Abbey” devotees may still be grieving over Lady Sybil’s death from eclampsia in last January’s [MORE]
Roche, Qiagen, BD, Novartis, Abbott, Hologic, Agilent/Dako, Cepheid, Seimens Healthcare and bioMérieux are the top ten makers of molecular [MORE]
Invasive lesion PDAC
“We were able to predict the appearance of cellular features and protein markers in the intermediate stages [MORE]
Late last year, the University of Pittsburgh Medical Center launched its $100m data warehouse project which aims to integrate [MORE]
The gold standard for diagnosing multiple sclerosis is the CT scan in which demylenated brain neurons show up as [MORE]
Using high throughput sequencing, scientists at Queen Mary University in London have carried out the largest sequencing study of [MORE]
Molecular Diagnostics
Amazon S3 and Google’s DNAnexus may not yet be familiar services, but they exist as businesses and [MORE]
Do cells use the electrical conductance of double stranded DNA to signal activation of repair proteins when needed? Jacqueline [MORE]
A research team from Stanford and Intel have designed what they hope will become a point-of-care proteomics array. Like [MORE]
In a paper titled “Systematic Identification of Genomic Markers of Drug Sensitivity in Cancer Cells,” a research group from [MORE]
Dr. Bert Vogelestein
A familiar assertion in “personalized medicine” is that DNA sequencing will be able to predict future health [MORE]
Ridge Diagnostics (San Diego, CA) has developed a panel of nine blood biomarkers that has a 90% sensitivity and [MORE]
In the most severe forms of Huntington’s disease, a glutamine-coding DNA sequence on chromosome 7, CAG, can be repeated [MORE]
Aptamers are oligonucleic acids or peptides that bind with specific molecules, and their existence has been known for about [MORE]